NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Finding Immune Nascent Type 1 Diabetes
Finding Immune Nascent Type 1 Diabetes

NCT07663136

Not Yet RecruitingNA

Sponsor: Indiana University

Conditions: Healthy Adult, Type 1 Diabetes (T1D)

Interventions: phone call, email/mail

Countries: United States

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

Eligibility overview

Sex: ALL

Age: 1 Year to 99 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Participant must be in Indiana Biobank
* Participant must be able to provide consent
* Ages 1-99 including pregnant women

Exclusion Criteria:

* Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study
* While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening
Locations (1)
  • Indianapolis, Indiana, United States